Dicyclomine

Back to search

Molecule Structure

Scientific Name

Dicyclomine

Description of the Drug

Dicyclomine is an antimuscarinic agent used to treat IBS.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00804

Brand Name(s)

Not Available

Company Owner(s)

Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, American Regent Inc, Mylan Pharmaceuticals Inc, Generics International Ventures Enterprises Llc, Allergan Sales Llc, Novitium Pharma Llc, Akorn Operating Co Llc, Fresenius Kabi Usa Llc, Fosun Pharma Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Muscarinic acetylcholine receptor M1 SINGLE PROTEIN ANTAGONIST CHEMBL216
Muscarinic acetylcholine receptor M3 SINGLE PROTEIN ANTAGONIST CHEMBL245

Unichem Links

SureChEMBL SCHEMBL3317
PharmGKB PA164744928
Human Metabolome Database HMDB0014942
DrugBank DB00804
PubChem: Thomson Pharma 15048766
PubChem 3042
Mcule MCULE-9110194493
NMRShiftDB 20208884
LINCS LSM-3534
Nikkaji J4.195E
BindingDB 50010101
EPA CompTox Dashboard DTXSID1022926
DrugCentral 868
Guide to Pharmacology 355
rxnorm DICYCLOMINE BENTYL DICYCLOMINE HYDROCHLORIDE
KEGG Ligand C06951
ChEBI 4514
ZINC ZINC000001530613